MedPath

The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study

Conditions
Prostate Cancer
Registration Number
NCT02041559
Lead Sponsor
Yonsei University
Brief Summary

Robot assisted prostatectomy reduces the patients' postoperative pain and leads to rapid rehabilitation. But pneumoperitoneum affects the kidney. The increase of stress hormone reduces the glomerular filtration and the vaso-contraction of renal vessels leads the renal ischemia. Remifentanil is analgesics coupled with μ opioid receptor. In high dose of remifentanil, it is associated with κ and δ receptors, which leads to renal protection effect in animal study. Also, remifentanil infusion during anesthesia showed a diuretic effect. The purpose of this study is to investigate the remifentanil effect on renal function during robot assisted prostatectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
1500
Inclusion Criteria
  • ages > 19 years and < 85 years
  • the patients undergoing a general anesthesia for robot assisted prostatectomy
Read More
Exclusion Criteria
  • incomplete record
  • history of opioid or steroid using
  • solitary kidney
  • history of kidney transplantation
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
acute kidney injury incidence based on Acute Kidney Injury Network criteria24 hours after end of surgery

Acute kidney injury incidence based on Acute Kidney Injury Network criteria was defined as increase in serum creatinine from baseline of ≥ 0.3 mg/dl within a 48-hour period. Acute kidney injury is evaluated at POD 1.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath